Skip to main content

Table 2 The efficacy of four doses of papaya CPs against high intensity T. suis infections

From: Cysteine proteinases from papaya (Carica papaya) in the treatment of experimental Trichuris suis infection in pigs: two randomized controlled trials

Treatment arm

n

Mean FEC at D-1 (EPG) (95% CI)

Mean FEC at D+6(EPG) (95% CI)

ERR (%) (95% CI)

Mean WC at D+7 (95% CI)

WRR (%) (95% CI)

CP45

6

500.0(41.7; 1,200)

5416.7(2200.0; 9233.3)

2.1*(-629.8; 68.9)

976.5(697.3; 1,256.1)

-14.0*(-213.7; 36.1)

CP115

6

233.3(16.7; 558.3)

1425.0(183.3; 2908.3)

74.2(-98.1; 96.9)

278.5(64.7; 551.7)

67.5(-3.4; 93.9)

CP225

6

241.7(50.0; 533.5)

808.3(208.3; 1741.7)

85.4(-15.4; 97.1)

160.3(61.3; 265.8)

81.3(43.7; 93.9)

CP450

6

441.7(25.0; 1,150.0)

41.7(0.0; 108.3)

99.2*(93.6; 100)

8.5(2.7; 15.7)

99.0*(97.0; 99.7)

Control

6

308.3(33.3; 733.3)

5533.3(758.3; 11608.3)

_

856.3(328.7; 1,384.0)

_

  1. The mean fecal egg counts (FEC) at day (D) -1, mean worm counts (WC) at D+7 and the reduction in WC at D+7 compared to the control group (WCR) for a single-oral dose of 45, 115, 225, and 450 μmol papaya CPs (P45, P115, P225 and P450).
  2. *pair-wise comparison between CP450 and CP45 revealed a significant difference with p-value <0.01.